[news] February 6th report Beijing (economic information daily) Kangmei Pharmaceutical (SH, 600518), said that the strategic cooperation with the Chongqing municipal government, the total amounted to 5 billion yuan, has made strategic progress.

In February 4th, Chongqing City Medical Group Chairman Wang Ping, Chongqing Nanchuan district Party committee secretary Li Mingqing and his party visited the U.S. pharmaceutical, and chairman of the board, the U.S. pharmaceutical general manager Ma Xingtian and vice chairman, deputy general manager Xu Dongjin and other executives on the strategic cooperation projects to promote exchanges and further deep into the great consensus.

Last September, the Chongqing municipal government reached a strategic partnership with the U.S. pharmaceutical, pharmaceutical intends to invest 5 billion yuan, full participation in the Chongqing city public hospital reform, "Internet plus medical wisdom and pharmacy, pharmaceutical logistics extension services and other large areas of the health service development, pharmaceutical pillar industry of Chongqing help create qianyiji production and" Internet plus big health industry cluster. It is understood that in building a production base in Chongqing, Chinese herbal medicine group medical system and the cooperation of public hospitals in the landing, is the focus of the content of the meeting to communicate.

According to reports, after nearly half a year to promote cooperation with Chongqing Kangmei pharmaceutical, medical, and other parties in Nanchuan District Chinese medicine innovation research platform construction, geoherbs seedling cultivation, Chinese herbal medicine production, Chinese medicine granule and traditional Chinese medicine production, "Internet plus medical service, and the reform of public hospitals and other areas are of strategic significance the progress of. In this regard, chairman and general manager of the United States and the United States and the pharmaceutical industry Ma Xingtian expressed satisfaction with the progress of bilateral strategic cooperation projects.

During the meeting, Chongqing medical group and Nanchuan District of the U.S. pharmaceutical industry status and demonstration effect affirmed, especially Kangmei pharmaceutical industry in the national standard of Chinese herbal medicine, Chinese herbal medicine, Chinese herbal medicine classification price index, bulk trading platform, Chinese medicine, health care and other Internet encoding formulation. It is precisely because of the confidence of the U.S. pharmaceutical industry status and products, the Chongqing municipal government hopes that the U.S. pharmaceutical business model and the traditional Chinese medicine products and services, can give people of Chongqing city and even the southwest people, bring a new safe, convenient and intimate health experience.

"Kangmei pharmaceutical is Chinese medicine industry leading enterprises, the first in response to the national" Internet plus "and" health China "strategy to establish a model for the industry. Kangmei pharmaceutical will give full play to "wisdom + health" model of development experience, combined with the city of Chongqing with the "new economy" "new normal" trends and requirements, based on the objective reality, constantly learning, together, win-win situation, to jointly promote the progress of the project." Ma Xingtian said, "in 2017, the U.S. pharmaceutical more hype, roll up your sleeves and go," health Chinese "boost construction process!"

Chongqing medical Holdings (Group) company was founded in August 2000, by the Chongqing municipal government funded the establishment of large-scale state-owned holding group company, authorized operation and management of Chongqing municipal chemical industry, pharmaceutical industry and salt industry, the state-owned holding shares of the production enterprises, industry supply and marketing company, professional companies and research institutes of the state-owned assets. The exercise of the authorized person within the scope of the rights of state-owned assets. Now has a wholly owned subsidiary of a subsidiary of 19 households, 8 households, a subsidiary of 6 households, the number of employees of wholly-owned subsidiary of 3.5 million people. 2015 full caliber sales revenue of 55 billion 600 million yuan, the group's total assets of more than 73 billion yuan, became the 2015 China enterprise 500 strong 341st.

Kangmei pharmaceutical was founded in 1997, in 2001, listed in the Shanghai Stock Exchange, is the first Internet layout of the whole industry chain with Chinese medicine, Chinese herbal medicine production as the core of traditional Chinese medicine, the whole industry chain to create a comprehensive health + platform + big data + service "system precision service" Internet plus large "listed enterprises, national high-tech enterprises. The company has total assets of 53 billion yuan, net assets of about 28 billion 500 million yuan, nearly three years as a national tax of about 4 billion 100 million yuan. Ranked among the top 500 companies in China, the world's top 2000 companies, Guangdong tax hundred, SSE Composite index is the 50 component, but also China's capital market, the market value of the first breakthrough billion yuan pharmaceutical companies.